User:Anthony Milto/Sandbox 1

This is a default text for your page Anthony Milto/Sandbox 1. Click above on edit this page to modify. Be careful with the < and > signs.

You may include any references to papers as in: the use of JSmol in Proteopedia ^[1] or to the article describing Jmol ^[2] to the rescue.

Structure

MyoD has a basic region at its amino-terminal end, which functions in binding the transcription factor to a region of the DNA known as the E-box. At the carboxyl-terminal end is MyoD's HLH domain. The HLH domain functions in protein-protein interactions and forms homodimeric and heterodimeric complexes 2. MyoD also contains an acidic activation domain. The activity of this activation domain has been observed to increase drastically upon deletion of residues in other parts of the protein. This suggests that the acidic activation domain is buried within the protein in vivo and can be activated by subtle changes in structure 3. MyoD's ability to activate endogenous genes has been shown to rely on two regions. The first is a region rich in cysteine and histidine residues that is between the acidic activation domain and the bHLH domain. The second is a region near the carboxyl terminus of the protein. These regions are conserved in proteins with shared functionality 4.

Regulation

MyoD is subject to regulation at both its bHLH domain and its acidic activation domain. MyoD functions as a transcriptional activator only as a heterodimer with E proteins, which are a sub-family of bHLH proteins. In one experiment, forced binding of E12 to MyoD that had been inhibited using E protein fragments robustly restored MyoD's activity 5. Differences in E-box sequences and in complex formation determine the transcription factor's effect and allow differentiation into a diverse array of muscle cells 2. The myogenic ability of MyoD is inhibited upon complex formation at the HLH domain with another bHLH protein known as Twist 6. It has been proposed that DNA binding, with its accompanying structural changes, is required in vivo to free the acidic activation domain and activate MyoD's myogenic functions 3.

DNA Interaction

Knockout Effects

Knockout mutations of the MyoD gene have been shown to produce no distinct skeletal muscle phenotype due to an increase in Myf5 activation. Mutants lacking both MyoD and Myf5 fail to develop skeletal musculature all together (REFERENCE)

This is a sample scene created with SAT to by Group, and another to make of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.